Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

		Keywords:		ANG1005

		Phase:		Phase 1

		Treatment ID#s:		VT1871 NCT00539344

		Age Group:		Adults Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		10/09/2008

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Glioblastoma Multiforme Gliosarcoma


		Comments:		Taxol is a drug that is effective for many cancers including breast and lung to name two. It works very well at killing brain tumor cells in a dish, but lacks the ability to get across the blood brain barrier to work effectively in patients. This study utilizes a 15 amnio acid peptide which is a ligand for a receptor that actively transports across the blood brain barrier, as well as into certain tumor cells like glioblastoma. The peptide has three molecules of taxol conjugated.

		Treatment Type:		Chemotherapy.

		Contact:		Dana-Farber/Harvard Cancer Center Clinical Trials Office - Dana-Farber/Harvard Cancer Center Dana Farber Cancer Institute Boston, MA 02115 Phone:617-582-8480 Email not available Columbia University Medical Center Steven Rosenfeld, MD Contact: Mary Ann Kral New York, NY 10032 Phone:212-305-7266 Click here to send an email MD Anderson Cancer Center Morris Groves, MD Contact: Teresa Hanna 1400 Holcombe Blvd Houston, TX 77030 Phone:713-563-1603 Click here to send an email Website: www.mdanderson.org/diseases/braincancer/ University of Virginia Health System David Schiff, MD Co-Director, Division of Neuro-Oncology Department of Neurology Box 800432 Charlottesville, VA 22908-0432 Phone:434-982-4415 Fax: 434-982-4467 Click here to send an email Website: www.uvabraintumor.com

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By